Xiaolan Ling
Impact in
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Protein Degradation and Inhibitors 1
- Cell death mechanisms and regulation 1
- Genetics 1
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Jianyong Chen (1 shared paper)Ayad Al‐Katib (1 shared paper)Sanjeev Banerjee (1 shared paper)Amro Aboukameel (1 shared paper)Zaneta Nikolovska‐Coleska (1 shared paper)Ramzi M. Mohammad (1 shared paper)Dajun Yang (2 shared papers)Shaomeng Wang (1 shared paper)
- Journals
- BMC Cancer (1 paper)Cancer Biology & Therapy (1 paper)Drug Discovery Today (1 paper)Journal of Computer Assisted Learning (1 paper)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Xiaolan Ling
4 papers receiving 45 citations
Peers
Comparison fields: 5 of 32
- Genetics 8
- Toxicology 2
- Molecular Biology 30
- Pathology and Forensic Medicine 4
- Oncology 6
Countries citing papers authored by Xiaolan Ling
This map shows the geographic impact of Xiaolan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Ling more than expected).
Fields of papers citing papers by Xiaolan Ling
This network shows the impact of papers produced by Xiaolan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Ling. The network helps show where Xiaolan Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 35 | |
| 2 | 2022 | 7 | |
| 3 | A novel pan inhibitor of Bcl-2 and Mcl-1 apogossypolone (ApoG2) with superior stability and improved activity against human leukemia and lymphoma cells. | 2007 | 3 |
| 4 | 2013 | 1 | |
| 5 | 2025 | 0 |
About Xiaolan Ling
Xiaolan Ling is a scholar working on Molecular Biology, Genetics, Radiological and Ultrasound Technology, Clinical Psychology and Oncology, having authored 5 papers that have together received 46 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Telemedicine and Telehealth Implementation (1 paper), Quality and Safety in Healthcare (1 paper), Protein Degradation and Inhibitors (1 paper), COVID-19 and Mental Health (1 paper), Cell death mechanisms and regulation (1 paper) and Research in Cotton Cultivation (1 paper). The work is most often cited by research in Genetics (8 citations), Toxicology (2 citations), Molecular Biology (30 citations), Pathology and Forensic Medicine (4 citations) and Oncology (6 citations). Xiaolan Ling has collaborated with scholars based in United States, China and France. Frequent co-authors include Jianyong Chen, Ayad Al‐Katib, Sanjeev Banerjee, Amro Aboukameel, Zaneta Nikolovska‐Coleska, Ramzi M. Mohammad, Dajun Yang, Shaomeng Wang, Yuan Sun and Jack Wu. Their work appears in journals such as BMC Cancer, Cancer Biology & Therapy, Drug Discovery Today and Journal of Computer Assisted Learning.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.